← Back to News
Addiction TreatmentNovember 18, 2026

Ibogaine vs Suboxone: The First 90 Days on Each Path

Most ibogaine vs Suboxone comparisons stop at the big picture: one is a maintenance medication taken daily for months or years, the other is a single supervised dose meant to interrupt dependence. That framing is accurate and not very useful on the day you have to choose. What people actually want to know is what each path looks like on day one, day three, week two and month three, and where the dangerous moments sit on each timeline. This article walks both paths side by side over the first 90 days. For the full head-to-head on cost, evidence and legality, our ibogaine vs suboxone comparison page covers that ground.

One caution before the timeline. People have died during and after ibogaine treatment, in clinics as well as outside them. Heart rhythm problems are the suspected cause in many of those deaths. Nothing in the weeks described below should be read as a promise about how your own treatment would go.

Ibogaine vs Suboxone: what each path is trying to do

Suboxone is buprenorphine combined with naloxone. Buprenorphine is a partial opioid agonist: it occupies the same receptors as heroin or oxycodone, relieves withdrawal and blunts cravings, and binds tightly enough to block most other opioids. It is approved by the Food and Drug Administration for opioid use disorder, it is Schedule III in the United States, and a physician can prescribe it. The goal is stability, and for many people that means staying on it indefinitely.

Ibogaine is a psychoactive alkaloid from the root bark of a West African shrub. Taken as a single large dose, it is reported to reduce acute opioid withdrawal and, for some people, cravings for weeks afterward. It is Schedule I in the United States. Mexico has not scheduled it, so it is unregulated there and not approved; a clinic can hold a health establishment license, and that license is not an approval of ibogaine. If the basics are new to you, start with what is ibogaine before reading on.

The evidence base is lopsided. A systematic review by Köck and colleagues in the Journal of Substance Abuse Treatment in 2022 found that the clinical evidence for ibogaine comes from open-label studies and case series, not from randomized trials, while buprenorphine's support comes from decades of randomized trials. No published ibogaine study has enrolled a fentanyl-using population, which is the population most people now asking this question belong to.

What happens before day one on each path?

On Suboxone, the first dose has a timing problem. Because buprenorphine binds so tightly, taking it while a full opioid is still active can trigger precipitated withdrawal, which is sudden and severe. Prescribers therefore wait until a patient is already in moderate withdrawal before the first dose, or use a slow low-dose start. Induction can happen in a clinic, an emergency department or at home under phone guidance, and the waiting period is often the worst part.

Before ibogaine, the preparation is longer and the stakes are different. A clinic should take an ECG, check potassium and magnesium and correct them before dosing, review every medication and ask about alcohol and benzodiazepine use. Heavy alcohol or benzodiazepine use must be stabilised first, because withdrawal seizures appear in the fatality reports. Some antidepressants block the liver enzyme that clears ibogaine and need weeks to wash out, not days; stopping one has its own risks and is done only with its prescriber.

Then there is the buprenorphine clearance problem, the part that makes this comparison different from any other. Buprenorphine is long-acting and binds tightly, so ibogaine given on top of it tends not to work and the withdrawal it is meant to relieve has not arrived yet. How long buprenorphine takes to clear depends on its form and dose, and a long-acting monthly injection can stay detectable for a year or more. Routine urine screens can miss it. Ask the clinic how it confirms buprenorphine has cleared, how many days before dosing it must stop and what the patient takes in the meantime.

Stopping buprenorphine carries its own overdose risk, and a reader does it with a prescriber, not alone. Any switch to a shorter-acting opioid before dosing is done by the treating clinic's physicians, where the treatment takes place. In the United States no prescriber can lawfully write a prescription for morphine or any other Schedule II opioid to treat opioid use disorder, so your own doctor cannot arrange this at home. Never bridge with opioids from any other source: those bought outside a pharmacy may contain fentanyl, and tolerance is already falling.

What do the first 72 hours look like?

Suboxone, days one to three. Once the first dose takes hold, withdrawal eases within an hour or two. The prescriber adjusts the dose over the next couple of days until cravings are controlled without sedation. Buprenorphine has a ceiling on how far it suppresses breathing, and that ceiling does not hold with alcohol, benzodiazepines or other sedatives. Its own effect on the QT interval is small, not zero, and how it combines with ibogaine's is not known.

Ibogaine, hours zero to seventy-two. The dose is given in a monitored room, usually with a test dose first. Within an hour or two the visionary phase begins and can last most of a day, with vomiting common. Potassium and magnesium should be checked and corrected again after vomiting. The person will need help walking for at least a day, and the cardiac monitor stays on throughout.

This is also a window in which deaths have been reported. Dangerous arrhythmias have occurred in monitored hospital patients and in unmonitored settings alike; monitored hospital patients have reached dangerous QT intervals. Monitoring can catch a dangerous rhythm early enough to treat it; it does not prevent one and can miss one. Magnesium is given at many clinics as a reasonable precaution, and no study has shown it prevents arrhythmia.

By the end of the third day most people are walking, eating a little and sleeping badly. Withdrawal symptoms are often reduced but not always absent. How the two paths compare at this point depends entirely on the person: one is stabilised on a daily medication, the other is three days into recovery from a physically demanding experience.

What changes in the first week after ibogaine vs the first week on Suboxone?

On Suboxone, the first week is dose-finding and side-effect management: constipation, sweating, sleep disruption and sometimes headaches are the common complaints. Counseling or group support usually starts here. The main risk in week one is stopping early because the dose feels wrong, which is a conversation with the prescriber, not a decision to make alone.

After ibogaine, the first week is where the risk people underestimate sits. The QT interval commonly stays long past the first day, and in reported cases for more than a week. Travel home follows a normal ECG, not a set number of days. Fainting, a racing or irregular heartbeat or a seizure is an emergency at any time, and that risk lasts at least the first week and until an ECG is normal. Until then no new medicine is started, anti-nausea drugs included, without asking a prescriber who knows about the ibogaine whether it affects the QT interval.

The other week-one risk is overdose. Opioid tolerance falls after ibogaine treatment, by an amount no one can predict, so a dose used before can be a fatal overdose. Opioids may also act more strongly than expected afterward. Leave with naloxone, make sure the people around you know how to use it, and call emergency services at the first sign of an overdose. Our step-by-step ibogaine guide covers what to settle with the clinic before you go home.

Weeks two to twelve: where the decisions concentrate

Suboxone, weeks two to twelve. For most people this period is quiet, which is the point. Doses stabilise, prescriptions move to monthly, and the work shifts to counseling, housing, employment and relationships. Some patients and prescribers begin to discuss tapering; many do not, and long-term maintenance is a recognised outcome, not a failure.

After ibogaine, weeks two to twelve. Cravings that were muted often begin to return somewhere in this window, and a reduction in withdrawal does not by itself change the circumstances that drove use. This is where aftercare decides outcomes: therapy, peer support, a sober living arrangement or a planned return to medication. Outcomes vary widely, with some people staying off opioids for a year or more and many returning to use within weeks.

The question that gets skipped is whether buprenorphine restarts. Some people choose ibogaine precisely to stop it; others plan to go back on it at a lower dose, or to have it available if cravings return. Settle with the treating physician, before leaving the clinic, whether and when buprenorphine restarts and who would prescribe it. Restarting any opioid after ibogaine happens in a body whose tolerance has fallen, which is why the naloxone advice above applies for weeks, not days.

How do you decide between ibogaine and Suboxone?

The comparison is not symmetrical. One path has a regulated supply, randomized evidence and a prescriber who answers the phone. The other has a single intense intervention, a thinner evidence base, a documented risk of death and a lot of weight placed on what happens afterward. Some people have been on buprenorphine for years and want a way off; some have tried it and found it did not hold; some have never tried it and are drawn to ibogaine first. Those are different situations and deserve different answers.

A few questions help. Have you tried buprenorphine at an adequate dose with real support, and what happened? Do you have a heart condition, a long QT, or a medication list that a clinic will have to work around? Do you have somewhere to go and someone to be with in the weeks after treatment? Can you say, in writing, what you will do if cravings return in week three? Whatever you answer, bring it to a prescriber who knows your history, and bring it to the clinic's physician before any deposit is paid.

Ibogaine vs Suboxone is less a contest than a choice between two timelines with different dangerous moments, and the honest comparison depends on where you are standing right now. Our ibogaine treatment guide collects the screening checklists, clinic questions and aftercare planning in one place so you can walk through both paths before committing to either.